Extavia
Links shared publicly online about this topic
Novartis, Betaseron, Extavia and Multiple Sclerosis - Health Blog - WSJ
blogs.wsj.com — “Selling a drug identical to one that's already on the market is just the start, the company hopes.” View full resource at blogs.wsj.com
Most Recently Shared on August 17, 2009 at 4:50 pm By:
William Yates, M.D. Family Medicine Doctor, Physician, Doctor, and Psychiatrist
Novartis enters multiple sclerosis treatment arena with copy of Bayer drug Betaseron. http://bit.ly/9JR88
Novartis, Betaseron, Extavia and Multiple Sclerosis - Health Blog - WSJ
blogs.wsj.com — “Selling a drug identical to one that's already on the market is just the start, the company hopes.” View full resource at blogs.wsj.com
Most Recently Shared on August 17, 2009 at 3:46 pm By:
Novartis’s Big Plans for Multiple Sclerosis http://bit.ly/TDCL0
European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Sclerosis Patients The Next Six Months
medicalnewstoday.com — “BioTrends Research Group, Inc. finds that while neurologists in the EU tend to prescribe the established interferon betas as their first line disease modifying agents (DMAs) for the treatment of m” View full resource at medicalnewstoday.com
Most Recently Shared on December 28, 2010 at 3:05 pm By:
European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Sclerosis ... http://mnt.to/3PwR
Important Information for Extavia® (interferon beta 1-b) Patients Regarding Triad Group's Alcohol Prep Products
fda.gov — “Novartis Pharmaceuticals Corporation (Novartis) has become aware of a United States market recall of all lots of alcohol prep pads, swabs and swabsticks manufactured by the Triad Group and marketed under various brand names. The recall has been initiated due to concerns about potential microbial contamination of the alcohol products with Bacillus cereus, that could potentially lead to life-threatening infections.” View full resource at fda.gov
Most Recently Shared on January 31, 2011 at 11:37 pm By:
Important Information for Extavia® (interferon beta 1-b) Patients Regarding Triad Group's Alcohol Prep Products http://bit.ly/h9WgT4
Novartis launches Extavia, a new therapeutic option to help patients combat devastating symptoms of multiple sclerosis
novartis.com — “Basel, January 22, 2009 - Novartis has today announced the launch of Extavia, a new version of the standard-of-care for relapsing forms of multiple sclerosis (MS), providing patients and physicians with an alternative option to help manage this devastating disease.” View full resource at novartis.com
Most Recently Shared on January 22, 2009 at 12:25 pm By:
eyeonfda Health Lawyer and Pharma
Novartis launches Extavia®, a new therapeutic option for patients with multiple sclerosis - http://is.gd/gOML
Important Information for Extavia (interferon beta 1-b) Patients Regarding Triad Group's Alcohol Prep Products
usrecallnews.com — “Some of these alcohol prep pads from Triad may have been included in U.S. packaging for Extavia, a product marketed by Novartis. The Triad alcohol prep pads should not be used.” View full resource at usrecallnews.com
Most Recently Shared on February 2, 2011 at 3:25 am By:
Important Information for Extavia (interferon beta 1-b) Patients Regarding Triad Group’s Alcohol Prep Products http://f.ast.ly/Xhexq
US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies From Novartis To Help Patients With This Devastating Disease
medicalnewstoday.com — “The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients man” View full resource at medicalnewstoday.com
Most Recently Shared on August 18, 2009 at 12:56 pm By:
MedNewsToday: US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies Fro.. http://bit.ly/MMOBo
US FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
novartis.com — “Basel, August 17, 2009 - The US Food and Drug Administration (FDA) has approved Extavia (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.” View full resource at novartis.com
Most Recently Shared on August 20, 2009 at 1:30 pm By:
eyeonfda Health Lawyer and Pharma
FDA approves Novartis' Extavia® for treatment of MS - http://bit.ly/sM6J3
Medications for MS: What--™s the difference between interferon beta-1a and interferon beta-1b? - Multiple Sclerosis
healthcentral.com — “Four of the seven currently available disease-modifying MS drugs are often referred to as “the interferons” - Avonex, Rebif, Betaseron, and Extavia....” View full resource at healthcentral.com
Most Recently Shared on December 1, 2010 at 4:36 pm By:
Medications for MS: What's the difference between interferon beta-1a and interferon beta-1b? http://ow.ly/1afB1E
Biogen Idec Sues Other MS Drug Makers - Health Blog - WSJ
blogs.wsj.com — “The biotech is suing the makers of multiple sclerosis drugs that, like its own Avonex treatment, are forms of beta interferon.” View full resource at blogs.wsj.com
Most Recently Shared on June 2, 2010 at 6:13 pm By:
Biogen Idec Sues Other MS Drug Makers: The biotech is suing the makers of multiple sclerosis drugs that, like its ... http://bit.ly/9MiYkE
Medical News: FDA Approves New Brand of Old MS Drug - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA approved a new brand of the multiple sclerosis drug interferon beta-1b, giving Novartis the green light to market the drug as Extavia.” View full resource at medpagetoday.com
Most Recently Shared on August 17, 2009 at 9:41 pm By:
FDA Approves New Brand of Old MS Drug http://ow.ly/15Ln3k
Drug Updates
nursingcenter.com — “No need to go searching all over for the latest information on new drugs, indications, medication errors and more. You can find the latest journal articles and CE activities from our 50+ nursing journals, plus get access to new drug information” View full resource at nursingcenter.com
Most Recently Shared on June 24, 2009 at 7:49 pm By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
The latest drug information from NursingCenter.com http://bit.ly/FkloG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
-
WSJ Health Blog
The WSJ Health Blog offers insight and analysis on health and health biz.
-
MNT Multiple Scl
The latest multiple sclerosis news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
